← Back
$LRMR All transactions

Larimar Therapeutics, Inc.

A

$ Value

$0

Shares

19,000

Price

$0

Filed

May 15

Insider

Name

Flynn James E

Title

CIK

0001352546

Roles

Director 10% Owner Other

Transaction Details

Transaction Date

2025-05-13

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

19,000

Footnotes

Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). | The option was granted on May 13, 2025 and is scheduled to vest on the earlier of May 13, 2026 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer. | This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Filing Info

Accession No.

0001193805-25-000672

Form Type

4

Issuer CIK

0001374690

Flynn James E's History

Date Ticker Type Value
2025-11-24 NUVL $35.4M
2025-11-24 NUVL $35.4M
2025-07-31 LRMR $10.8M
2025-07-31 LRMR $10.8M
2025-07-31 LRMR $8.3M
2025-06-27 SPRY $6.8M
2025-06-27 SPRY $6.8M
2025-06-18 NUVL A $0
2025-06-18 NUVL A $0
2025-06-18 NUVL A $0

Other Insiders at LRMR (90d)

Insider Bought Sold Last
Celano Michael
Chief Financial Officer
2026-01-26
BEN-MAIMON CAROLE
President and CEO
2026-01-26
Clayton Russell
Chief Medical Officer
2026-01-26
Shankar Gopi
Chief Development Officer
2026-01-26